1. Home
  2. HOS vs NVAX Comparison

HOS vs NVAX Comparison

Compare HOS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HOS

Hornbeck Offshore Services Inc. Common Stock

N/A

Current Price

$6.86

Market Cap

2.6B

Sector

Energy

ML Signal

N/A

Logo Novavax Inc.

NVAX

Novavax Inc.

SELL

Current Price

$11.24

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HOS
NVAX
Founded
1997
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
HOS
NVAX
Price
$6.86
$11.24
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$13.00
★ $14.22
AVG Volume (30 Days)
2.3M
★ 8.1M
Earning Date
11-08-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 309.76
EPS
★ 0.06
N/A
Revenue
$876,561,000.00
★ $1,123,479,000.00
Revenue This Year
$78.64
N/A
Revenue Next Year
$45.63
N/A
P/E Ratio
$111.67
★ N/A
Revenue Growth
3.60
★ 64.69
52 Week Low
$6.57
$6.20
52 Week High
$9.41
$13.39

Technical Indicators

Market Signals
Indicator
HOS
NVAX
Relative Strength Index (RSI) 27.29 50.30
Support Level N/A $7.93
Resistance Level $8.16 $11.73
Average True Range (ATR) 0.35 1.13
MACD -0.06 0.01
Stochastic Oscillator 21.81 28.62

Price Performance

Historical Comparison
HOS
NVAX

About HOS Hornbeck Offshore Services Inc. Common Stock

Hornbeck Offshore Services Inc, through its subsidiaries, operates offshore supply vessels (OSVs), multi-purpose support vessels (MPSVs), and a shore-base facility. It provides marine transportation, logistics support, and related services to customers in the offshore oil and gas industry, in the U.S. Gulf Coast region, Latin America, and other international markets. The company also serves non-oilfield markets, including military support services, renewable energy projects, and other marine service activities. The majority of revenue is derived from the provision of vessel management services to external vessel owners and from providing shore-based port facility services.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: